Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

18
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
18
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

16
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
16
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

15
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
15

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laminin γ1 chain is essential for the cardiorespiratory and muscular systems.

Matrix biology : journal of the International Society for Matrix Biology·2025
Same author

Integrin α10β1-selected mesenchymal stem cells reduced hypercoagulopathy in a porcine model of acute respiratory distress syndrome.

Respiratory research·2023
Same author

A Semi-quantitative Scoring System for Green Histopathological Evaluation of Large Animal Models of Acute Lung Injury.

Bio-protocol·2022
Same author

Monitoring lung injury with particle flow rate in LPS- and COVID-19-induced ARDS.

Physiological reports·2021
Same author

Organ-restricted vascular delivery of nanoparticles for lung cancer therapy.

Advanced therapeutics·2021
Same author

Toxicological effects of zinc oxide nanoparticle exposure: an <i>in vitro</i> comparison between dry aerosol air-liquid interface and submerged exposure systems.

Nanotoxicology·2021

Related Experiment Video

Updated: Jul 30, 2025

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

384

Current and Future Engineering Strategies for ECMO Therapy.

Deniz A Bölükbas1,2,3,4, Sinem Tas1,2,3,4

  • 1Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.

Advances in Experimental Medicine and Biology
|May 17, 2023
PubMed
Summary

Extracorporeal membrane oxygenation (ECMO) offers life support for severe respiratory failure by oxygenating blood externally. Ongoing technological advancements focus on improving gas exchange efficiency and reducing complications for better patient outcomes.

More Related Videos

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.5K
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

1.9K

Related Experiment Videos

Last Updated: Jul 30, 2025

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

384
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.5K
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

1.9K

Area of Science:

  • Biomedical Engineering
  • Cardiopulmonary Physiology

Background:

  • Extracorporeal membrane oxygenation (ECMO) is a critical intervention for patients with severe respiratory failure.
  • It functions by externalizing gas exchange when lung capacity is critically compromised.

Purpose of the Study:

  • To review the fundamental principles of ECMO therapy.
  • To highlight recent technological advancements and experimental strategies in ECMO.
  • To discuss future directions for more efficient ECMO system designs.

Main Methods:

  • Review of existing ECMO technologies and principles.
  • Analysis of current research trends and experimental approaches.
  • Synthesis of information on circuit design and anticoagulant use.

Main Results:

  • ECMO facilitates oxygen diffusion and carbon dioxide removal outside the body.
  • Technological evolution aims to enhance gas exchange and minimize anticoagulant requirements.
  • Current research focuses on optimizing circuit compatibility and performance.

Conclusions:

  • ECMO remains a vital, albeit complex and costly, therapy for respiratory failure.
  • Continuous innovation is crucial for improving ECMO efficacy and safety.
  • Future ECMO designs will likely prioritize enhanced efficiency and reduced complications.